OT
OS Therapies Inc
SEC filingBiotechnology · Grasonville, MD
Amount raised$5Msold at filing
Total offering$10M$5M still open
Investors in the raise10count reported to the SEC
FiledAug 25, 2026first sale Aug 10, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
John P. CiccioDirector
Olivier P. JarryDirector
Avril P. McKean DieserDirector
Robert G. PetitExecutive Officer
Christopher P. AcevedoExecutive Officer
Craig P. EagleDirector
Theodore F. SearchDirector
Paul A. RomnessExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.